Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more
- PMID: 23685907
- PMCID: PMC3739248
- DOI: 10.1038/aja.2013.57
Androgen-deprivation therapy in men with metastatic prostate cancer: less may not necessarily be more
Comment on
-
Intermittent versus continuous androgen deprivation in prostate cancer.N Engl J Med. 2013 Apr 4;368(14):1314-25. doi: 10.1056/NEJMoa1212299. N Engl J Med. 2013. PMID: 23550669 Free PMC article. Clinical Trial.
References
-
- Grossmann M, Zajac JD. Management of side effects of androgen deprivation therapy. Endocrinol Metab Clin North Am. 2011;40:655–71. - PubMed
-
- Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR, et al. Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer. 1993;71:2782–90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
